US Diabetes Care Drugs Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2026
US diabetes care drugs market is anticipated to grow significantly over the forecast period (2020-2026). The key factor that drives the growth of the market includes the presence of a large pool of patients suffering from diabetes in the country. As per International Diabetes Federation, the number of adults suffering from diabetes in the country was 31.0 million peoples in 2019, which is projected to reach up to 34.4 million peoples in 2030, which is further predicted to reach 36.0 million in 2045.
To Request a Sample of our Report on US Diabetes Care
Drugs Market: https://www.omrglobal.com/request-sample/us-diabetes-care-drugs-market
Hence, the increased cases of diabetes are likely
to prompt the demand for the proper treatment, which in turn, will provide
growth opportunities for the US diabetes care drugs industry to grow in the
near future.
Further, the government and other organizational
support, to create awareness regarding the treatment and early diagnosis of the
disease is also expected to propel the growth of the US diabetes care drugs
market over the forecast period. Some of the awareness programs include the
National Diabetes Prevention Program, American Diabetes Association, and other
Diabetes Awareness and Prevention Campaigns.
Furthermore, the footprints of major players
operating in the market such as Bayer AG, Bausch Health Companies Inc.,
Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Eli Lilly
and Co., Merck & Co. Inc., Novartis International AG, Novo Nordisk A/S,
Pfizer Inc., Sanofi SA, Takeda Pharmaceuticals Industries Ltd. among others
support the market growth.
Market Coverage
·
Market number available for – 2019-2026
·
Base year- 2019
·
Forecast period- 2020-2026
·
Segment Covered- By Drug Class
·
Country Covered- the US
·
Competitive Landscape- Bayer AG, Bausch Health Companies
Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Eli
Lilly and Co., Merck & Co. Inc., Novartis International AG, Novo Nordisk
A/S, Pfizer Inc., and Takeda Pharmaceuticals Industries Ltd
(Get 15% Discount on Buying this Report)
A
full Report of US Diabetes Care Drugs Market is Available at: https://www.omrglobal.com/industry-reports/us-diabetes-care-drugs-market
US Diabetes Care Drugs Market – Segmentation
By Drug Class
·
Insulins
·
Non-Insulin Injectable Drugs
·
Oral Anti-Diabetic Drugs
·
Combination Drugs
Company Profiles
·
AstraZeneca Plc
·
Bayer AG
·
Bausch Health Companies Inc.
·
Boehringer Ingelheim International GmbH
·
Bristol Myers Squibb Co.
·
Eli Lilly and Co.
·
Johnson & Johnson Services Inc.
·
Merck & Co. Inc.
·
Mylan NV
·
Nectar Therapeutics
·
Novartis International AG
·
Novo Nordisk A/S
·
Pfizer Inc.
·
Sanofi SA
·
Sun Pharma Industries Ltd.
·
Takeda Pharmaceuticals Industries Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment